Koate Articles
BioMarin gains US patent on Aldurazyme
5 August 2002
Baxter's 2nd qtr sales below forecasts
29 July 2002
Baxter's 2nd-qtr sales below forecasts
29 July 2002
DSM set to build new plant in Canada
15 July 2002
Octapharma to buy Biovitrum plasma unit
8 July 2002
PAION gets $4.8M development grant
8 July 2002
Baxter files in USA for albumin-free rFVIII
8 July 2002
Ariad files law suit against Eli Lilly
1 July 2002
IDM enter Medarex partnership
17 June 2002
Plasma protein potential highlighted at meeting
17 June 2002
Serono's cool.click device cleared in EU
10 June 2002
Genzyme's Thyrogen cleared in Canada
10 June 2002
Wyeth to stop work on heart attack drug
20 May 2002
Ferring gets US OK for infertility drug
13 May 2002
Dendreon hit by FDA Provenge request
6 May 2002
Bayer boosts first qtr income 18.3%
6 May 2002
Strong earnings growth at Baxter
29 April 2002
Corvas slumps 47% on negative rNIF study
29 April 2002
Serono reports 10.4% 1st-qtr sales increase
29 April 2002
BioMarin starts Ph II trial of MPS VI drug
29 April 2002
Profit warning at Novo Nordisk
22 April 2002
Oxxon licenses MVA tech from Alpharma
15 April 2002
Baxter expands in Europe
15 April 2002
Net loss deepens at PPL Therapeutics
1 April 2002
PPL hit by delay to lead drug for emphysema
25 March 2002
Baxter outlines growth strategy
25 March 2002
Bayer reflects on "sobering" 2001
18 March 2002
Baxter building units in Austria and Cz Rep
18 March 2002
New ECoJ opinion backs parallel importer
18 March 2002
Indian medicinal plant database to be set up by Reliance
25 February 2002
BioStratum seeks US OK for cancer drug trials
18 February 2002
Gradipore and Biomira sign recombinant protein pact
18 February 2002
Scios benefits from Natrecor launch
18 February 2002
Pretax profits up 25% at Novo Nordisk
18 February 2002
Chiron Corp 2001 revenues top $1 bill
11 February 2002
GSK to start trials of first HIV vaccine candidate
4 February 2002
Phytomedics, DNAX forge deal on protein production in plants
28 January 2002
Tally of NCEs in 2001 lends credence to talk of R&D productivity
21 January 2002
GSK licenses rights to Scios' Natrecor
14 January 2002
Improved hep B vaccine from Corixa/Rhein
14 January 2002
Peregrine sets up contract manufacturing unit
14 January 2002
Bayer's pharmaceuticals head leaves as partnership rumors arise
14 January 2002
Chinese firm to start endostatin trials
14 January 2002
Dragon files for EPO use in surgery
7 January 2002
Merck & Co is utilizing Recombumin with Delta's vaccine
7 January 2002
Merck & Co is utilizing Recombumin with Delta's vaccine
19 December 2001
Meristem research agreement with Mitsubishi Pharma
12 December 2001
Millennium and Xoma link up on drug development
27 November 2001
Pfizer gets backing from Indian govt
26 November 2001
Chiron sepsis drug fails at final hurdle
21 November 2001
New safety data on Amgen's Kineret bode well for its use in RA
14 November 2001
Chugai and Suntory move osteoporosis drug into Phase I
14 November 2001
New services from Cytomyx
12 November 2001
Pretax profits up 33% at Novo Nordisk
7 November 2001
Dragon gains Indian, and other, OKs for EPO drug
6 November 2001
BioPartners licenses sustained release hGH from Korea's LG Chem
1 November 2001
Losses deepen at BioMarin
26 October 2001
Galapagos and P&G sign genomics deal
24 October 2001
Bavarian Nordic outlines smallpox vaccine programs
18 October 2001
Baxter boosts oncology business with Epoetin Omega buy
17 October 2001
Celltech to merge with Biogen?
5 October 2001
Zonagen suspends primate contraceptive vaccine trial
3 October 2001
Alizyme starts trials of mucositis drug
3 October 2001
Affitech forges antibody deal with Isogenica
3 October 2001
DGCI asks Dr Reddy's to recall cancer drug
1 October 2001
Japanese pharma stocks - week to September 24
26 September 2001
"Vast" potential for sepsis therapeutics
19 September 2001
FDA approves Baxter's 3rd suite at Bioscience facility
13 September 2001
Betatropin therapy data in type 2 diabetes
11 September 2001
Antisoma reports full-year progress
10 September 2001
BioMarin demonstrates potential of rhASB as MPS therapy
7 September 2001
Extended labeling for Serono's Saizen approved in EU
16 August 2001
Bayer to cut prices in Medicaid fraud deal
15 August 2001
FDA OKs Scios' CHF drug, first in a decade
14 August 2001
EC issues marketing OK for Aventis Pasteur HBV vaccine
9 August 2001
Promising data for Lilly/ET oral osteoporosis drug
6 August 2001
China: drug price cuts lead to competition
2 August 2001
Xoma initiates Ph II Neuprex trial in Crohn's
2 August 2001
FDA approves Rebetol as separate treatment
31 July 2001
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
